![Suzanne Fleming](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Suzanne Fleming
No open positions remaining
Profile
Suzanne Fleming is currently the Chief Accounting Officer at Beam Therapeutics, Inc. She previously held positions as the Senior Director-Finance at TransForm Pharmaceuticals, Inc. from 2003 to 2005, Principal at Transkaryotic Therapies, Inc., Principal at Oculon Corp from 1991 to 1995, Principal at CytoTherapuetics, Inc. from 1995 to 1998, Vice President-Finance at AVEO Pharmaceuticals, Inc. from 2005 to 2013, Treasurer, Chief Financial & Accounting Officer at Epizyme, Inc. from 2017 to 2019, and Vice President-Finance at Foundation Medicine, Inc. from 2014 to 2017.
She obtained her undergraduate degree from Stonehill College, Inc.
Former positions of Suzanne Fleming
| Companies | Position | End |
|---|---|---|
| EPIZYME, INC. | Director of Finance/CFO | 2019-01-30 |
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | 2017-08-31 |
| AVEO PHARMACEUTICALS, INC. | Director of Finance/CFO | 2011-04-04 |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Director of Finance/CFO | 2004-12-31 |
CytoTherapuetics, Inc.
 CytoTherapuetics, Inc. Financial ConglomeratesFinance Biological Products | Corporate Officer/Principal | 1997-12-31 |
Training of Suzanne Fleming
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Commercial Services |
Oculon Corp
 Oculon Corp Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
CytoTherapuetics, Inc.
CytoTherapuetics, Inc. Financial ConglomeratesFinance Biological Products | Finance |
Stonehill College, Inc.
 Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
- Stock Market
- Insiders
- Suzanne Fleming
